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http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose: BfmR, the response regulator component of the two-component system
BfmRS, has important roles in biofilm formation and cellular morphology of Acinetobacter bau-
mannii. Until now, the contribution of the sensor kinase BfmS to the virulence of this bacter-
ium remains unknown. In this study, a bfmS knockout and complementation studies were
performed to clarify the role of BfmS in A. baumannii virulence.
Methods: We constructed a bfmS knockout mutant in the A. baumannii 17978 type strain by
transposon inactivation. To clarify the role of bfmS in A. baumannii virulence, the biofilm forma-
tion, adherence ability to eukaryotic cells, serum resistance, and antibiotic susceptibility tests
were performed in A. baumannii 17978 and its derivative knockout and complementation strains.
Results: The bfmS knockout displayed a reduction in biofilm formation, loss of adherence to eu-
karyotic cells, and greater sensitivity to serum killing compared with the parent strain. Proteomic
analysis of culture supernatants revealed that the release of outer membrane proteins (Omps),
including CarO and outer membrane protein A (OmpA), was associated with the inactivation of
BfmS in A. baumannii.3, Chung-Yang Road, Hualien City 970, Taiwan.
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17978 Type st
bfmS::Km bfmS::E
bfmS::KmC bfmS::K
E. coli strains
DH5a Used fo
Plasmids
pGEM-T-easy High-co
pGEM-bfmS pGEM-T
pGEMT-bfmS::km bfmS::E
pWH1266 E. colie
pAB0749 pWH12
Primers 50 to 30
bfmS-FP TTGCTC
bfmS-RP TTATGC
bfmS-RTFP TCGGC
bfmS-RTRP GCCTCA
bfmR-FP ATGTTG
bfmR-RP TTACAA
a Ampr Z ampicillin resistance; KmConclusion: This study is the first to demonstrate that the pathway regulated by the sensor kinase
BfmS is associated with biofilm formation, adherence to biotic surfaces, serum resistance, and
antibiotic susceptibility, which may be associated with the release of Omps in A. baumannii.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acinetobacter baumannii is an important nosocomial
human pathogen.1 The widespread virulence of A. bau-
mannii strains is thought to depend on the expression of
virulence factors that enable bacterial infection and the
expression of antimicrobial-resistant determinants.2,3 The
remarkable resistance phenotype may be facilitated by
the ability of A. baumannii strains, particularly those iso-
lated from catheter-related urinary or bloodstream infec-
tions, to form biofilms that adhere to and persist on abiotic
surfaces.4 Moreover, a novel pilus assembly system,5 a
homologue of staphylococcal biofilm-associated protein
(Bap),6 and quorum sensing7 are involved in A. baumannii
biofilm formation. Similarly, adherence of A. baumannii to
human epithelial cells could contribute to the initial step
of colonization on biotic surfaces, which is enhanced by
the presence and expression of the blaPER-1 gene.
8 Fur-
thermore, resistance to serum killing could explain the high
mortality in patients with an ultimately fatal underlying
disease, septic shock at the onset of bacteremia, and
mechanical ventilation.9 Among the virulence factors
reported in A. baumannii, outer membrane protein A
(OmpA) plays a versatile role in A. baumannii pathogenic
processes including biofilm formation on abiotic surfaces,
adherence to eukaryotic cells, and the inhibition of com-
plement via recruitment of factor H to the cell surface.10ids and oligonucleotide primer
t characteristic(s)a
rain
Z-Tn5<R6Kgori/KAN-2>derivat
m harboring pAB0749
r recombinant DNA methods
py-number cloning vector; Amp
vector containing bfmS gene
Z-Tn5<R6Kgori/KAN-2>derivat
A. baumannii shuttle vector A
66 harboring the 17978 bfmS al
GAACTTCCAATTTATTATAC
AGGTGCTTTTTTATTGGTC
GGGTATTACCTTATTTAGCT
ATCAAACGCTGAATATGGT
CCGGGTGCAGAT
TCCATTGGTTTCTTTAACAA
r Z kanamycin resistance; Tcr ZHowever, the mechanisms of OmpA-mediated patho-
genesis and the regulatory processes controlling these
mechanisms remain to be characterized.
Bacterial two-component systems (TCSs) are key factors
in the ability of microorganisms to survive and grow in
various environments.11 TCSs have been studied in many
bacteria, particularly in their control of the virulence
mechanisms of those microorganisms.12,13 However, much
less is known about TCS-mediated virulence in A. bau-
mannii. BfmRS is a TCS in A. baumannii ATCC 19606 that
controls biofilm formation and cellular morphology.14 This
transcriptional regulatory system activates the expression
of the usherechaperone assembly system responsible for
the production of pili needed for biofilm formation on
polystyrene surfaces. TCSs such as PhoPQ are examples of
regulatory systems that control antimicrobial peptide
resistance, survival within macrophages, and virulence in
animal models and human volunteers.13,15 It is possible that
A. baumannii BfmRS, in addition to its role in biofilm for-
mation, could participate in virulence mechanisms such as
cell adhesion and resistance to serum killing, which is
associated with OmpA-mediated pathogenesis.15 To test
this hypothesis, we constructed a bfmS knockout mutant in
the A. baumannii 17978 type strain by transposon inacti-
vation. We show in this report that bfmS gene may play dual
roles in A. baumannii virulence and antibiotic susceptibility
via the loss or inactivation of Omps.s used in this study
Source or reference
American Type Culture Collection
(Manassas, VA)
ive of 17978 This study
This study
Invitrogen
r Promega
This study
ive of pGEM-bfmS This study
prTcr Gaddy et al. [18]
lele; Ampr This study
This study
This study
This study
This study
This study
This study
tetracycline resistance.
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Bacterial strains, plasmids, and primers
The bacterial strains, plasmids, and primers used in this
study are listed in Table 1. Bacteria were routinely cultured
at 37C in LuriaeBertani (LB) medium.Insertion mutagenesis and genetic
complementation
DNA purification, restriction, ligation, agarose gel electro-
phoresis, and transformation of Escherichia coli were
performed using standard protocols.16 The bfmS::Km
mutants were constructed using the method as described.14
Briefly, a 1368-bp DNA fragment, corresponding to the
bfmS DNA region, was amplified by polymerase chain
reaction (PCR) using primers bfmS-FP and bfmS-RP. The
amplified fragment was cloned into plasmid pGEM-T-easy to
form pGEM-bfmS. A mutagenesis plasmid pGEM-bfmS::km
was generated with the EZ-Tn5<R6Kgori/KAN-2>Insertion
kit (Epicentre Inc., Madison, WI, USA). Plasmid pGEM-
bfmS::km was transformed into A. baumannii ATCC 17978
by electroporation, and bacteria were selected on LB agar
containing kanamycin. The bfmS::Km mutants were verified
by PCR using primer set 1 (bfmR-FP and bfmS-RP) and set 2
(bfmS-FP and bfmS-RP) as shown in Table 1. In com-
plementation experiment, the bfmS parental allele was
PCR amplified using primers bfmS-FP and bfmS-RP and was
ligated into A. baumanniieE. coli shuttle vector pWH1266
and transformed into E. coli Top10 cells. Recombinant
plasmid DNA, named pAB0749, was electroporated into
A. baumannii 17978 cells. The presence and stability of
pAB0749 in the complemented strain was confirmed by
restriction analysis.Reverse transcriptase-PCR
Total RNA was isolated from all the parental and mutant
strains using an acidephenol extraction protocol.16 The
concentration and quality of the RNA in each sample were
determined by measuring absorbance at 260 nm. All RNAs
were adjusted to a concentration of 50 ng mL1. The
reverse transcriptase (RT)-PCR protocol was carried out
using the MMLV High Performance Reverse Transcriptase Kit
(Epicentre). The expression of each target gene was then
normalized to that of the 16S rRNA gene. The primers used
for determination of bfmS and bfmR gene expression by RT-
PCR are listed in Table 1.Biofilm assays
Biofilm formation on polystyrene was assessed by crystal
violet staining of cells cultured in LB broth as previously
described.17 Each experiment was performed in triplicate
and repeated three times. The quantity of biofilm in each
sample was normalized to that of the parental strain.A549 cell adhesion assays
Cell adhesion assays were performed as previously descri-
bed.18 Briefly, A549 human alveolar epithelial cells were
cultured in Dulbecco’s modified Eagle’s medium (Invitrogen,
San Diego, CA, USA) at 37C in 5% CO2. All cells were grown
in 10-cm culture-coated Petri dishes and seeded to 70%
confluence in six-well plates or on sterile coverslips placed
in six-well plates for experiments. Bacterial cells (2  106
CFU) were added and co-cultured with A549 cells for 1 hour
at 37C. The infected monolayers were washed with
phosphate-buffered saline (PBS) and lysed in 1 mL sterile
deionized water. The lysates were plated on LB agar plates
to determine the number of bacteria that attached to A549
cells. Each experiment was performed in triplicate and
repeated three times. The number of adherent bacteria in
each sample was normalized to that of the parental strain.
Serum bactericidal assay
Serum bactericidal assays were performed according to the
procedure.10 Briefly, normal human sera (NHS) were col-
lected from five healthy donors. The pooled NHS was
aliquotted and stored at 20C until further use. A. bau-
mannii overnight cultures were washed with PBS and
adjusted to a final concentration of 1  109 CFU mL1 with
PBS. Then, 200 mL PBS containing 20% NHS was prepared
and mixed with 10 mL bacterial suspension (1  107 cells)
and incubated with shaking for 2 hours at 37C. Next,
200 mL PBS without NHS was used as a positive control. The
number of surviving bacteria in each sample was deter-
mined by serial dilution and plating on LB agar at 37C for
18e24 h. The survival rate of bacteria was calculated as the
number of surviving bacteria in 20% NHS divided by those
without NHS.
Protein identification by matrix-assisted laser
desorption/ionization time-of-flight mass
spectroscopy
The overnight cultures of bacteria cells were harvested by
centrifugation, and supernatants were concentrated 20-
fold using a Vivaspin concentrator (GE Healthcare) with
10 kDa MW cutoff. The purified proteins were analyzed
using SDS-polyacrylamide gel (12%) electrophoresis. Gels
were stained with Coomassie brilliant blue, and selected
bands were manually excised from the gels and trans-
ferred to microcentrifuge tubes and subjected to in-gel
trypsin digestion according to a standard protocol.19
After digestion, the samples were analyzed using a
matrix-assisted laser desorption/ionization (MALDI)-time
of flight (TOF) mass spectrometer 4800 Proteomics Ana-
lyzer (Applied Biosystems). Peptide masses were searched
against a comprehensive nonredundent protein
database (NCBInr) using the mascot program for protein
identification.20
Antimicrobial susceptibility testing
Antimicrobial susceptibility was determined with the
microdilution method in accordance with the guidelines of
278 M.-L. Liou et al.the Clinical and Laboratory Standards Institute.21 The
agents tested included ceftazidime, amikacin, cipro-
floxacin, and imipenem. E. coli strain ATCC 25922 and
Pseudomonas aeruginosa strain ATCC 27853 were used as
references in the susceptibility testing. A more than
twofold reduction or induction in the minimum inhibitory
concentration (MIC) values in the bfmS::Km mutant
compared to their parental strain was considered
significant.Statistical analysis
Differences were determined using the paired Student t-
test. A p value <0.05 was considered statistically sig-
nificant. Data entry and analyses were performed using theAmp
Km
A1S_0749
(bfmS)
A1S_0748
(bfmR)
A1S_0749
(bfmS)
A1S_0748
(bfmR)
Km
PF-Smfb
bfmR-FP
bfmS-RTFP
1
bfmR
bfmS
16S rRNA
2 3
bfmR-RP
A
B
Figure 1. Construction and identification of the transposon inse
frames are represented by arrows. The dotted lines denote homolo
bfmS::km and the 17978 chromosome. Amp Z ampicillin resistan
analysis of total RNA isolated from 17978 (lane 1), bfmS::Km (lan
mers used to analyze the transcription of bfmS and bfmR are listeStatistical Package for the Social Sciences software version
15.0 (SPSS Inc., Chicago, IL, USA).Results
Characterization of the bfmS locus in the bfmS::Km
mutant
The insertion mutant bfmS::Km was constructed from
A. baumannii ATCC 17978 (Fig. 1A). After the gene con-
struction procedure, the electroporated pGEM-T-
bfmS::km homologous recombined with the bfmS gene
in A. baumannii ATCC 17978. PCR detection of the
transposon insertion using primer set 1 (bfmR-FP and
bfmS-RP) and set 2 (bfmS-FP and bfmS-RP) showed 4222-A1S_0749
pGEMT-bfmS::km
A1S_0750
17978 chromosome
A1S_0750
bfmS::Km
knockout mutant
chromosome
PR-Smfb
bfmS-RTRP
rtion mutant bfmS::Km. (A) The orientations of open reading
gous recombination between the bfmS gene located in pGEMT-
ce cassette; Km Z kanamycin resistance cassette. (B) RT-PCR
e 2), and bfmS::KmC (lane 3) cells cultured in LB broth. Pri-
d in Table 1.
Figure 2. Virulence assay in 17978, bfmS::Km, and
bfmS::KmC cells. (A) Quantitative biofilm assays. Fold change
is determined as the quantity of biofilm in each sample nor-
malized to that of 17978 strain. (B) Bacterial adhesion on A549
human alveolar epithelial cells. Fold change is defined as the
number of adherent bacteria in each sample normalized to
that of the 17978 strain. (C) Killing of bacteria in normal human
serum. The data are normalized as the number of surviving
bacteria in 20% NHS divided by the number of surviving bacteria
incubated without NHS. Error bars, 1 standard deviation (SD).
*p < 0.05, **p < 0.01, ***p < 0.001.
Figure 3. Inactivation of bfmS leads to increased release of
proteins into culture supernatants. Total proteins from crude
cell proteins and filtered supernatants were extracted from
17978 (lanes 1 and 4), bfmS::Km (lanes 2 and 5), and
bfmS::KmC (lanes 3 and 6) cells were analyzed on 12.5% pol-
yacrylamide gels. Three proteins released by bfmS::Km strain
are indicated by arrows.
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Fig. 1B shows the result of the mRNA expression of the
bfmR and bfmS genes in the bfmS::Km, bfmS::KmC, and
their parental strain. The mRNA levels of bfmS in
bfmS::KmC were restored to levels similar to those of the
parental strain. However, the mRNA levels of bfmR were
not significantly reduced in the bfmS::Km strain relative
to the parent strain despite an absence of bfmS mRNA
expression.Virulence assay
Fig. 2A shows the result of quantitative biofilm assays.
The growth rate did not differ in bfmS::Km, bfmS::KmC,
and their parental strain (data not shown). A significant
reduction (p < 0.05) in biofilm formation in the bfmS::Km
strain was observed compared to the 17978 type strain. In
contrast, a recovery in biofilm formation was shown in the
bfmS::KmC strain (p < 0.01). Fig. 2B shows the result of
adherence to A549 cells by bfmS::Km, bfmS::KmC, and
their parental strain. Quantitative adherence assays
showed a significant reduction (p < 0.01) in adherence
capability in bfmS::Km compared with the 17978 type
strain. A partial recovery in adherence capability was
observed in the bfmS::KmC strain (p < 0.05). Fig. 2C shows
the survival rate of the ATCC 17978 type strain and
bfmS::Km mutant cells incubated with 20% NHS. The 20%
NHS concentration was selected for the serum bactericidal
assay based on the study.10 A significant reduction of the
survival rate in bfmS::Km was observed compared to the
17978 type strain (p < 0.001). A partial reversal in serum
resistance was observed in the bfmS::KmC strain (p < 0.05).Characterization of supernatant proteins in
bfmS::Km mutant
Fig. 3 shows the result of cellular and supernatant protein
profiles in bfmS::Km, bfmS::KmC, and their parental strain.
The cellular protein profiles were not different in the three
strains. However, three protein bands were found in the
bfmS::Km supernatant and were then identified as OmpA,
Table 2 Proteins identified by MALDI-TOF-MS-MS analysis of supernatants from bfmS::Km strains
Protein Identity Source species GenBank accession
number
Sequence coverage
of matched peptides
Theoretical Mr/pI
a Outer membrane protein A A. baumannii YP_001085848 42% 7279
b Chain A, N276d Mutant Of
E. coli Tem-1 b-Lactamase
E. coli 1CK3_A 89% 5418
c CarO A. baumannii YP_001085557 51% 5190
MALDI-TOF Z matrix-assisted laser desorption/ionization-time of flight; MS Z mass spectrometry.
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shown in Table 2.
Antimicrobial susceptibility testing
The changes in secreted protein profiles suggest that the
inactivation of bfmS in A. baumannii may lead to an
increased resistance to antibiotics. Table 3 shows the sus-
ceptibility result of A. baumannii mutants and their
parental strains. The increase of MIC to ciprofloxacin and
the decrease of MIC to imipenem were observed in the
bfmS::Km mutant. The partially restored MIC values to the
two drugs were found in the bfmS::KmC strain.
Discussion
This study is the first to demonstrate that the insertional
inactivation of bfmS in the A. baumannii ATCC 17978 type
strain results in deficient biofilm formation on abiotic sur-
faces, reduction of adherence to eukaryotic cells, and
sensitization to serum killing.
Omps play important roles in antimicrobial resistance
and/or virulence in Gram-negative bacteria.22 Among all
the surface proteins reported to date, A. baumannii OmpA
mediates interactions with epithelial cells and then targets
the nucleus, resulting in cytotoxicity.23 Moreover, this
protein is also found in the outer membrane vesicles that
could induce A. baumannii OmpA (AbOmpA)-dependent
host cell death.24 The mouse pneumonia model showed
that the AbOmpA mutant has some defects in serum
resistance or the ability to disseminate into the blood.23 All
study results imply that OmpA has been implicated in vir-
ulence, both in cell culture and in animal models of A.
baumannii pathogenesis, and was modeled to contribute to
biofilm formation. To date, the regulatory processesTable 3 Susceptibility of A. baumannii mutants and their
parental strains
Antibiotic MIC (mg/L) a
17978 bfmS::Km bfmS::KmC
Ceftazidime 16 16 16
Ciprofloxacin 0.25 2 1
Amikacin 2 2 2
Imipenem 2 <0.25 1
a Significant change is indicated in bold.
MIC Z minimum inhibitory concentration.controlling the OmpA-mediated virulence remain unclear.
Our study shows the loss or secretion of AbOmpA into
bfmS::Km culture supernatants, suggesting that the inac-
tivation of bfmS may affect the regulatory process and/or
translational modification of OmpA leading to loss of viru-
lence in A. baumannii despite the fact that ompA mRNA
levels were not different in the mutants and their parental
strains (data not shown).
Loss of Omps is one of the important mechanisms that
contribute to antimicrobial resistance in Gram-negative
bacteria.25,26 In A. baumannii, CarO was previously shown
to form nonselective pores, and a loss or inactivation of this
porin has been associated with increased resistance to
carbapenems.26 The upregulatory mechanism of CarO
remains to be characterized; however, our result shows
that inactivation of bfmS may affect the translational
modification of CarO resulting in the secretion of CarO into
culture medium. Moreover, the carO mRNA levels were
significantly increased in the bfmS::Km mutants (data not
shown), suggesting that bfmS may modulate the mRNA
expression of carO in A. baumannii. The antimicrobial
susceptibility result shows that the inactivation of bfmS
could alter the MICs to ciprofloxacin and imipenem, sug-
gesting that bfmS may play dual roles in antimicrobial
resistance and virulence. Notably, the decrease in imipe-
nem MIC found in bfmS knockout mutant was associated
with the increased mRNA expression in that strain, implying
that CarO may play an important role in the resistance to
carbapenem in A. baumannii.26
There is one notable difference between the studies of
Tomaras et al14 and ours. Tomaras et al reported that the
biofilm formation of the 19606 type strain depends on the
production of Csu pili chaperoneeusher assembly system,
which is regulated by bfmR. Nevertheless, bfmS plays a
less relevant role in biofilm formation. Our study shows
that the inactivation of bfmS could reduce biofilm for-
mation in A. baumannii ATCC 17978. Moreover, the defi-
ciency of biofilm formation in the Km::bfmS mutant is
associated with the repression of csuA mRNA expression
(data not shown). One possible explanation for these
results is that modulation of bfmS either at the chromo-
somal level or in phenotypic characterization might differ
among strains. Detailed mechanisms for such differences
remain to be elucidated. In conclusion, this report is the
first demonstration that BfmS mediates multiple virulence
processes in A. baumannii. The identification and charac-
terization of the BfmS-mediated regulatory system will be
required for a fuller understanding of the pathobiology of
this bacterium.
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